EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 3.0

A Randomised Controlled Trial of Tripterygium Wilfordii Polyglycoside in the Long-Term Treatment of Stage IV Diabetic Kidney Disease (DKD)

Ban Zhao, Xin Dang, Yuan Wang, Tianhui Li, Aiqun Chen, Liping Yang, Yonghui Mao

Drug Design, Development and Therapy · 2026-11 · Volume 20 · 1-21

DOI: 10.2147/dddt.s640159 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Drug Design, Development and Therapy, 2026-11. Verfasst von Ban Zhao und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Zhao, B., Dang, X., Wang, Y., Li, T., Chen, A., Yang, L., & Mao, Y. (2026). A Randomised Controlled Trial of Tripterygium Wilfordii Polyglycoside in the Long-Term Treatment of Stage IV Diabetic Kidney Disease (DKD). Drug Design, Development and Therapy, Volume 20, 1-21. https://doi.org/10.2147/dddt.s640159

Vancouver

Zhao B, Dang X, Wang Y, Li T, Chen A, Yang L, et al. A Randomised Controlled Trial of Tripterygium Wilfordii Polyglycoside in the Long-Term Treatment of Stage IV Diabetic Kidney Disease (DKD). Drug Design, Development and Therapy. 2026;Volume 20:1-21. doi:10.2147/dddt.s640159

BibTeX
@article{Zhao2026,
  author = {Zhao, Ban and Dang, Xin and Wang, Yuan and Li, Tianhui and Chen, Aiqun and Yang, Liping and Mao, Yonghui},
  title = {A Randomised Controlled Trial of Tripterygium Wilfordii Polyglycoside in the Long-Term Treatment of Stage IV Diabetic Kidney Disease (DKD)},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  volume = {Volume 20},
  pages = {1--21},
  doi = {10.2147/dddt.s640159}
}
Kostenlos starten →